Hind Alhumaidan
- Immunology
- Epidemiology
- Infectious Diseases
- Management of Technology and Innovation top 10%
- Molecular Biology
- Co-authors
- Saud AlarifiMohammed N. Al‐AhdalZahid HussainFahad N. AlmajhdiFaisal M. SanaiAhmed A. Al‐QahtaniHamad I. Al‐AshgarMashael R. Al‐Anazi
- Topics
- Hepatitis B Virus Studies (4 papers)Hepatitis C virus research (4 papers)Renal Transplantation Outcomes and Treatments (3 papers)
- Partner nations
- Saudi ArabiaUnited StatesNetherlands
In The Last Decade
Hind Alhumaidan
17 papers receiving 237 citations
Peers
Comparison fields: 5 of 75
- Immunology 67
- Epidemiology 48
- Infectious Diseases 45
- Management of Technology and Innovation 33
- Molecular Biology 30
Countries citing papers authored by Hind Alhumaidan
This map shows the geographic impact of Hind Alhumaidan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind Alhumaidan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind Alhumaidan more than expected).
Fields of papers citing papers by Hind Alhumaidan
This network shows the impact of papers produced by Hind Alhumaidan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind Alhumaidan. The network helps show where Hind Alhumaidan may publish in the future.
Co-authorship network of co-authors of Hind Alhumaidan
This figure shows the co-authorship network connecting the top 25 collaborators of Hind Alhumaidan. A scholar is included among the top collaborators of Hind Alhumaidan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hind Alhumaidan. Hind Alhumaidan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 11 | |
| 7 | 42 | |
| 8 | 6 | |
| 9 | 19 | |
| 10 | Computer vision syndrome prevalence, knowledge and associated factors among Saudi Arabia University Students: Is it a serious problem? | 24 |
| 11 | 2 | |
| 12 | 30 | |
| 13 | 7 | |
| 14 | 11 | |
| 15 | 47 | |
| 16 | 7 | |
| 17 | 9 | |
| 18 | 1 | |
| 19 | Bone marrow examination in staging of Lymphoma: Revisited. | 1 |
About Hind Alhumaidan
Hind Alhumaidan is a scholar working on Transplantation, Hepatology and Hematology, having authored 19 papers that have together received 241 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). The work is most often cited by research in Medical Laboratory Technology (10 citations), Management of Technology and Innovation (33 citations) and Hepatology (29 citations). Hind Alhumaidan has collaborated with scholars based in Saudi Arabia, United States and Netherlands. Frequent co-authors include Saud Alarifi, Mohammed N. Al‐Ahdal, Zahid Hussain, Fahad N. Almajhdi, Faisal M. Sanai, Ahmed A. Al‐Qahtani, Hamad I. Al‐Ashgar, Mashael R. Al‐Anazi, Ayman A. Abdo and Hazem Ghebeh. Their work appears in journals such as Blood, Journal of Medical Virology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.